Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04014075
Title DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Daiichi Sankyo, Inc.

stomach cancer

gastroesophageal junction adenocarcinoma


Trastuzumab deruxtecan

Age Groups: adult | senior
Covered Countries USA | ITA | ESP | BEL

No variant requirements are available.